Search
for
Sort by
Research 61–90 of 664
- Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients
- Male pattern baldness and the risk of prostate cancer
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Ottawa, Ontario, Canada, February 13–16, 2013
- Prostate Cancer Early Detection, Version 2.2015
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Finasteride, To Take, or Not to Take
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Trailing the Path to Preventive Oncology
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Subject Index
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- 1994 Forthcoming educational events
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study
- Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer